Defining professionalism in medical publications: transparency, objectivity and ethics

Abstract

Online SummaryThis supplement features 15 abstracts selected (via a peer-review process) from those presented at the 5th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) - Defining Professionalism in Medical Publications: Transparency, Objectivity, and Ethics, April 20-22, 2009, Philadelphia, PA, USA:Public website disclosure of corporate publication policies and procedures among pharmaceutical companies; How clear is transparent? A content analysis of transparency statements used within medical and scientific peer-review publications; Benchmarking medical publication policies, procedures, and practices across pharmaceutical companies; Public availability of pharma policies on their role in peer-reviewed publications; Observations on shifting preferences for planning, writing, and management of scientific publications; The role of medical publications in determining access, coverage, and reimbursement policy for health plans; Achieving best practice: benefits of an electronic publications planning tool; Review of online publication policies: pharmaceutical companies and medical colleges; A survey of accredited US medical school policies regarding collaboration with industry on secondary publications; Beliefs of US KOLs regarding professionalism in pharmaceutical company-sponsored medical publications;Evidence-based approach to publication planning; Strengthening the collaboration between authors and publication planners: recommendations from a publications advisory board; A survey of medical journals' acceptance of the role of professional medical writers in peer-reviewed publications; Development of clinically impactful, scientifically relevant and wholly transparent academic publications: an 8-step, best-practices approach to quality and compliance; Clinical trial data disclosure: impact on publication policies and disposition